טוען...
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...
שמור ב:
| הוצא לאור ב: | Diab Vasc Dis Res |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/ https://ncbi.nlm.nih.gov/pubmed/33307785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|